—A recent meta-analysis of 35 studies showed that TURP was associated with lower odds of early and persistent LUTS compared with ablation and enucleation. After surgery for benign prostatic ...
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results We conducted a prospective ...
In a human pilot study, the Intilume system for robotic-assisted en bloc resection was successfully performed in 9 of 11 patients with suspected bladder tumors. Robotic-assisted transurethral en bloc ...
In a trial, ERAS for ambulatory TURBT showed promise for improving early recovery compared with usual care. In a trial, quality of recovery was significantly better for patients receiving an enhanced ...
Medicare will typically cover TURP surgery if a doctor determines it is medically necessary for treating benign prostatic hyperplasia (BPH). Coverage varies based on hospital status. Medicare Part A ...
UGN-102 shows a 79.6% complete response rate in recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer. UGN-102 offers a non-surgical alternative, avoiding cystoscopy and anesthesia, ...
Nearly 200,000 Americans are living with muscle-invasive bladder cancer (MIBC), a severe and fast-growing type of bladder cancer that penetrates the thick muscle layer of the bladder wall. After ...
Richard T. Bryan, PhD, Wenyu Liu, PhD, Sarah J. Pirrie, MSc, Rashid Amir, FRCR, Jean Gallagher, Ana I. Hughes, MSc, Kieran P. Jefferson, FRCS, Allen Knight, MBA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results